Publications
PHE, S. OGER, D. BEHR-ROUSSEL, P. DENYS, E. COMPERAT, F. GIULIANO, E. CHARTIER-KASTLER.
Spontaneous contractile activity of human neurogenic bladder strips: Can we predict a correlation with between clinical factors, urodynamics and histological features ?
EAU, European Urology Supplements – 2012 : 11; e472
PHE, D. BEHR-ROUSSEL, S. OGER, E. CHARTIER-KASTLER, T. GHONEIM, T. LEBRET, G. KARSENTY, E. COMPERAT, P. CAMPARO, P. VALIDIRE, F. GIULIANO.
Evidence for a functional role of connexin 43 and 45 in human neurogenic detrusor overactivity
EAU, European Urology Supplements – 2012 : 11, e369
BEHR-ROUSSEL, S. OGER-ROUSSEL, B. PIGNOL, E. PHAM, A. LE MAUX, P.E. CHABRIER, P. PICAUT, S. CAISEY, S. COMPAGNIE, F. GIULIANO, P. DENYS.
Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO)
EAU, European Urology Supplements – 2012 : 11; e462
BEHR-ROUSSEL D, OGER-ROUSSEL S, CAISEY S, KERGOAT M, CHARON C, AUDET A, BERNBABE J, GIULIANO F.
Erectile and bladder dysfunctions in the type 2 diabetic Goto-Kakizaki rat.
ESSM, J. Sex. Med – 2012 : 9, suppl 4, 183-298
BEHR-ROUSSEL D., OUDOT A., OGER-ROUSSEL S., GORNY D., SANDNER P., BERNABE J., ALEXANDRE L., GIULIANO F.
Targeting both the dynamic and static components of LUTS/BPH using a soluble guanylate cyclase stimulator compared to vardenafil: preclinical evidences
EAU, European Urology Supplements 2013 : e900
BEHR-ROUSSEL D, OGER-ROUSSEL S, CAISEY S, KERGOAT M, CHARON C, AUDET A, BERNBABE J, GIULIANO F.
Bladder and erectile dysfunctions in the type 2 diabetic Goto-Kakizaki rat
EAU, European Urology Supplements 2013 : e449
HUYNH LE MAUX A., PIGNOL B., BEHR-ROUSSEL D., BLACHON J-L., CHABRIER P.E., PICAUT P., BERNABE J., GIULIANO F., DENYS P.
Does reduction of number injection sites of abobotulinum toxin A impact efficacy in Neurogenic Detrusor Overactivity (NDO) in the spinal cord-injured (SCI) rat model?
TOXINS, Toxicon 93S(2015), e127
HUYNH LE MAUX A., PIGNOL B., BEHR-ROUSSEL D., BLACHON J-L., CHABRIER P.E., PICAUT P., BERNABE J., GIULIANO F., DENYS P.
Does reduction of number injection sites of abobotulinum toxin A impact efficacy in Neurogenic Detrusor Overactivity (NDO) in the spinal cord-injured (SCI) rat model?
AUA, J. Urol – 2015 : Vol. 193, Issue 4, e36
J. MAIGNEL-LUDOP, B. PIGNOL, D. GORNY, R. ASSALY, D. BEHR-ROUSSEL, J. KRUPP
Human and mouse isolated bladder preparations are not equally affected by botulinum neurotoxin serotypes A and B
TOXINS; Toxicon 123(2017):S59
BADV, F. EL SAYED, J. FAUGEROUX, D. BEHR-ROUSSEL, M. ROTTMAN, T. DIDAR.
Perfluorocarbon Omniphobic Treatment Prevents Bacterial Colonization Of Urinary Catheter In A Rat Model
IDWeek; OFID – 2018 : 5(Suppl 1): S618–S619.
